UK Government (Department for Health and Social Care; Home Office)
In general, the activities are related to development of assays and testing of reagents. During 2020 active projects involving the following organisms and/or toxinswere undertaken:
Highly pathogenic influenza virus – reagent development for highly pathogenic avian influenza (HPAI) viruses (H5Nx, H7N9) and associated research.
Bacillus anthracis toxins – made available for vaccine testing, reagent development, development of in vitro assays to detect anthrax toxin neutralising antibodies.
Botulinum toxins (serotypes A, B, E) - laboratory testing of therapeutic toxins; development of cell-based assays for clostridial toxins.
(4) Respecto de las instalaciones que contengan unidades de contención máxima y participen en el programa nacional de investigación y desarrollo para la defensa biológica, indíquese el nombre de la instalación y anótese: "Declarada con arreglo al formulario A, parte 2 (iii)".
(5) Con arreglo a la versión más reciente del Manual de Bioseguridad en el Laboratorio de la OMS, o a otra norma equivalente.